0000899243-20-010623.txt : 20200409
0000899243-20-010623.hdr.sgml : 20200409
20200409201337
ACCESSION NUMBER: 0000899243-20-010623
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200407
FILED AS OF DATE: 20200409
DATE AS OF CHANGE: 20200409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GREEN JOHN B
CENTRAL INDEX KEY: 0001243847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36281
FILM NUMBER: 20785806
MAIL ADDRESS:
STREET 1: C/O DICERNA PHARMACEUTICALS, INC.
STREET 2: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Dicerna Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001399529
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205993609
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
BUSINESS PHONE: 617 621 8097
MAIL ADDRESS:
STREET 1: 33 HAYDEN AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-07
0
0001399529
Dicerna Pharmaceuticals Inc
DRNA
0001243847
GREEN JOHN B
C/O DICERNA PHARMACEUTICALS, INC.
33 HAYDEN AVENUE
LEXINGTON
MA
02421
0
1
0
0
Chief Financial Officer
Common Stock
2020-04-07
4
M
0
7501
5.45
A
26922
D
Common Stock
2020-04-07
4
M
0
12968
2.97
A
39890
D
Common Stock
2020-04-07
4
S
0
20469
19.95
D
19421
D
Employee Stock Option (Right to Buy)
5.45
2020-04-07
4
M
0
7501
0.00
D
2026-04-14
Common Stock
7501
211999
D
Employee Stock Option (Right to Buy)
2.97
2020-04-07
4
M
0
12968
0.00
D
2027-01-03
Common Stock
12968
14063
D
Includes shares acquired under the DRNA 2014 Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(c).
The reporting person sold an aggregate of 20,469 shares of common stock on April 7, 2020 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 3.11% of 659,052 shares of common stock, which is the number of shares of common stock owned by the reporting person prior to the Shares Sold transactions reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the reporting person as of the date of this report.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2019.
The option vested 25% after the first year anniversary of the vesting start date of April 14, 2016 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
The option vests in 48 monthly installments over the four-year period starting on the last day of January 2017, subject in each case to the reporting person's continued service with the issuer through the applicable vesting date.
/s/ John B. Green
2020-04-09